Autoimmune diseases refer to a bodys abnormal immune response leading to production of antibodies that attack own cells and tissues, causing deterioration and destruction of healthy tissues. There are almost 80 types of autoimmune diseases prevailing worldwide including systemic lupus erythematosus or rheumatoid arthritis. According to the estimation by American Autoimmune Related Diseases Association (AARDA), autoimmune disease affects up to 50 million Americans and 75% of them are females. The tests used to diagnose the autoimmune disease include auto antibody test, antinuclear antibody test, complete blood count, C-reactive protein, and erythrocyte sedimentation rate.

๐‹๐ข๐ฌ๐ญ ๐จ๐Ÿ ๐Š๐ž๐ฒ ๐๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ :

The key players operating in this market are AstraZeneca, F. Hoffmann-La Roche, Novartis AG, Pfizer Inc., Sanofi-aventis, Abbott Laboratories, Beckman Coulter Inc., Inova Diagnostics Inc., Bio-Rad Laboratories Inc., and Hemagen Diagnostics Inc.


๐ƒ๐จ๐ฐ๐ง๐ฅ๐จ๐š๐ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ https://www.alliedmarketresearch.com/request-sample/2698


๐Š๐„๐˜ ๐…๐ˆ๐๐ƒ๐ˆ๐๐†๐’ ๐Ž๐… ๐“๐‡๐„ ๐’๐“๐”๐ƒ๐˜

  • The study provides an in-depth analysis of the global autoimmune disease diagnostic market along with current trends and future estimations to elucidate the imminent investment pockets.
  • It presents a quantitative analysis from 2016 to 2023 to enable the stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of the market by product assists to understand the various forms of autoimmune disease diagnostic available.
  • Key players are profiled and their strategies are analyzed thoroughly to predict the competitive outlook of the market.


๐…๐จ๐ซ ๐๐ฎ๐ซ๐œ๐ก๐š๐ฌ๐ž ๐ˆ๐ง๐ช๐ฎ๐ข๐ซ๐ฒ https://www.alliedmarketresearch.com/purchase-enquiry/2698

This global market is segmented on the basis of type, product, service, technology, and region. Based on type, it is bifurcated into localized autoimmune disease diagnostic and systemic autoimmune disease diagnostic. Based on product, it is divided into drugs, therapeutic & monitoring equipment, and diagnostic equipment. Based on technology, it is divided into bridge therapy, disease-modifying antirheumatic drugs (DMARD), topical therapy, phototherapy, helminthic therapy, and recombinant technology. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of โ€œMarket Research Reportsโ€ and โ€œBusiness Intelligence Solutions.โ€ AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com

Leave a comment

Your email address will not be published.